Literature DB >> 1370330

Immunoreactive prostatic specific antigen in male periurethral glands.

H A Frazier1, P A Humphrey, J L Burchette, D F Paulson.   

Abstract

Prostatic specific antigen (PSA) is considered an antigen unique to benign and malignant prostatic tissue. Recent evidence in the literature has raised serious doubts about the specificity of this antigen. In this study twenty male urethral specimens were evaluated for PSA and prostatic acid phosphatase (PAP) from patients without evidence of prostatic cancer. Eight of these 20 urethral specimens exhibited strong immunostaining for both PSA and PAP, localized in the periurethral glands. Five of the 17 urethral biopsies were positive for both antigens, while all three of the whole mount autopsy specimens stained positive for PSA and PAP. Within the autopsy series, there was heterogenous staining of the periurethral glands within the same specimen. This evidence disproves the fact that PSA and PAP are organ specific as previously described. More than likely any tissue of cloacal origin has potential for staining positive for prostatic specific antigen and prostatic acid phosphatase.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370330     DOI: 10.1016/s0022-5347(17)37206-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  [Radical prostatectomy - pro laparoscopic].

Authors:  H M Do; S Holze; H Qazi; A Dietel; T Häfner; E Liatsikos; J-U Stolzenburg
Journal:  Urologe A       Date:  2012-05       Impact factor: 0.639

2.  Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects).

Authors:  Kenneth V Honn; Amer Aref; Yong Q Chen; Michael L Cher; John D Crissman; Jeffrey D Forman; Xiang Gao; David Grignon; Maha Hussain; Arthur T Porter; Edson J Pontes; Bruce Redman; Wael Sakr; Richard Severson; Dean G Tang; David P Wood
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

3.  The potential use of prostatic secretory protein of 94 amino acid residues (PSP94) as a serum marker for prostatic tumor.

Authors:  H von der Kammer; C Jurincic-Winkler; R Horlbeck; K F Klippel; H U Pixberg; K H Scheit
Journal:  Urol Res       Date:  1993-05

Review 4.  Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance.

Authors:  Zacharoula Panteleakou; Peter Lembessis; Antigone Sourla; Nikolaos Pissimissis; Aristides Polyzos; Charalambos Deliveliotis; Michael Koutsilieris
Journal:  Mol Med       Date:  2008-12-03       Impact factor: 6.354

Review 5.  A brief review of ultrasensitive prostate-specific antigen assays for the evaluation of patients after radical prostatectomy.

Authors:  T K Takayama; R L Vessella; P H Lange
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

Review 6.  Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer.

Authors:  Andrej Jedinak; Kevin R Loughlin; Marsha A Moses
Journal:  Oncotarget       Date:  2018-08-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.